Overview

Prostate Cancer Active Surveillance Metformin Trial

Status:
Withdrawn
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
To determine whether the use of metformin in patients with low-risk prostate cancer can delay progression to clinically significant prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
University Health Network, Toronto
Treatments:
Metformin